文献速递免疫规划卫生政策与健康促进

2012-2021年瑞士出生队列的儿童疫苗接种覆盖率及地区差异:我们是否步入正轨?

Childhood vaccination coverage and regional differences in Swiss birth cohorts 2012-2021: Are we on track?
PubMed 文献 · Vaccine · 2023-10-27

基于瑞士医保理赔数据的回顾性观察研究,纳入2012-2021年出生队列儿童120,073名,评估DTaP-IPV-Hib、MMR、HBV、PCV和MCV疫苗接种覆盖率与及时性。结果显示2019年国家免疫规划修订与上述疫苗全程覆盖率增加约10个百分点相关,但全程覆盖率仍低于90%,且存在地区差异,农村和德语区儿童更可能完全未接种。

要点

  • 2019年国家免疫规划修订与DTaP-IPV-Hib、MMR和HBV全程覆盖率增加约10个百分点相关。
  • 全程疫苗接种覆盖率仍低于90%,许多疫苗接种延迟或未完成。
  • 农村和德语区儿童更可能完全未接种,存在较大地区差异。

核心结论

  • 瑞士儿童全程疫苗接种覆盖率仍低于90%,许多疫苗接种延迟。
  • 鉴于地区差异、遗漏或延迟的加强接种以及疫苗特异性接受度差异,可能需要更多努力以实现国家疫苗接种目标。

研究设计与样本

  • 回顾性观察研究,使用瑞士医保理赔数据,纳入2012-2021年出生队列儿童,分别持续观察至13、25和48月龄。
  • 共纳入120,073名儿童,代表相应年份所有瑞士出生儿童的12%至17%。
  • 使用人口加权比例和事件时间分析描述覆盖率与及时性,采用逻辑回归探究与未接种相关的地区因素。

主要发现

  • 疫苗接种覆盖率多年来保持稳定或改善。
  • 2019年国家免疫规划修订与DTaP-IPV-Hib、MMR和HBV全程覆盖率增加约10个百分点相关。
  • 全程疫苗接种覆盖率仍低于90%,许多疫苗接种延迟或未完成。
  • 不同疫苗间覆盖率差异较大。
  • 农村和德语区儿童更可能完全未接种。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Many western countries are challenged by delayed and insufficient vaccination coverage rates in children, and thus missing WHO coverage targets. This study aimed to estimate vaccination coverage and timeliness in Swiss children over a decade. Furthermore, we evaluated the impact of COVID-19, regional variations, and the adherence to the amended vaccination schedule in 2019. METHODS: Retrospective observational study with Swiss health insurance claims data including birth cohorts 2012-2021 of children continuously observed until ages 13, 25, and 48 months respectively. We used population-weighted proportions and time-to-event analyses to describe coverage and timeliness of diphtheria/tetanus/pertussis/poliomyelitis/haemophilus influenzae type b (DTaP-IPV-Hib), measles/mumps/rubella (MMR), hepatitis B (HBV), pneumococcal (PCV), and meningococcal (MCV) vaccinations according to the national schedule. The potential impact of COVID-19 and vaccination schedule adherence were evaluated descriptively. Logistic regression was used to investigate regional factors potentially associated with non-vaccination. RESULTS: 120,073 children, representing between 12 and 17 % of all Swiss children born in corresponding years, were included. Coverage remained stable or improved over the years. The 2019 amendment of the national immunization schedule was associated with an increase of ~10 % points in full coverage in Swiss children for DTaP-IPV-Hib, MMR and HBV despite the concurrent COVID-19 pandemic. Nonetheless, full vaccination coverage remained below 90 % with many vaccination series being delayed or not completed. The comparison across the different vaccines revealed large differences in coverage. Moreover, we observed large regional differences in non-vaccination with children living in rural and German-speaking areas more likely to be entirely unvaccinated. CONCLUSION: Full vaccination coverage in Swiss children is still below 90 % with many vaccinations administered delayed. Given regional differences, missed or delayed booster vaccinations, and differences in vaccine-specific acceptability, more effort may be needed to achieve national vaccination targets.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zürcher SJ, Signorell A, Léchot-Huser A, et al. Childhood vaccination coverage and regional differences in Swiss birth cohorts 2012-2021: Are we on track? Vaccine. 2023. PMID: 38593195. doi:10.1016/j.vaccine.2023.10.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。